Related references
Note: Only part of the references are listed.miR-205 targets angiogenesis and EMT concurrently in anaplastic thyroid carcinoma
Haleh Vosgha et al.
ENDOCRINE-RELATED CANCER (2018)
MUC13 protects colorectal cancer cells from death by activating the NF-κB pathway and is a potential therapeutic target
Y. H. Sheng et al.
ONCOGENE (2017)
Cellular expression, &ITin-vitro&IT and &ITin-vivo&IT confirmation of GAEC1 oncogenic properties in colon cancer
Riajul Wahab et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2017)
MicroRNA-186-5p overexpression modulates colon cancer growth by repressing the expression of the FAM134B tumour inhibitor
Farhadul Islam et al.
EXPERIMENTAL CELL RESEARCH (2017)
MicroRNA-542-3p inhibits oral squamous cell carcinoma progression by inhibiting ILK/TGF-β1/Smad2/3 signaling
Bin Qiao et al.
ONCOTARGET (2017)
The roles of microRNA-34b-5p in angiogenesis of thyroid carcinoma
Hamidreza Maroof et al.
ENDOCRINE (2017)
Interactive role of miR-126 on VEGF-A and progression of papillary and undifferentiated thyroid carcinoma
Ali Salajegheh et al.
HUMAN PATHOLOGY (2016)
MicroRNA-126 suppresses proliferation of undifferentiated (BRAFV600E and BRAFWT) thyroid carcinoma through targeting PIK3R2 gene and repressing PI3K-AKT proliferation-survival signalling pathway
Md. Atiqur Rahman et al.
EXPERIMENTAL CELL RESEARCH (2015)
Downregulation of microRNA-498 in colorectal cancers and its cellular effects
Vinod Gopalan et al.
EXPERIMENTAL CELL RESEARCH (2015)
Modulatory role of miR-205 in angiogenesis and progression of thyroid cancer
Ali Salajegheh et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2015)
A p-Menth-1-ene-4,7-diol (EC-1) from Eucalyptus camaldulensis Dhnh. Triggers Apoptosis and Cell Cycle Changes in Ehrlich Ascites Carcinoma Cells
Farhadul Islam et al.
PHYTOTHERAPY RESEARCH (2015)
MicroRNA-34 Family, Mechanisms of Action in Cancer: A Review
Hamidreza Maroof et al.
CURRENT CANCER DRUG TARGETS (2014)
Role of microRNA-34 family in cancer with particular reference to cancer angiogenesis
Hamidreza Maroof et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2014)
MicroRNAs Regulate Tumor Angiogenesis Modulated by Endothelial Progenitor Cells
Prue N. Plummer et al.
CANCER RESEARCH (2013)
Co-regulatory potential of vascular endothelial growth factor-A and vascular endothelial growth factor-C in thyroid carcinoma
Ali Salajegheh et al.
HUMAN PATHOLOGY (2013)
Efficient Biodistribution and Gene Silencing in the Lung epithelium via Intravenous Liposomal Delivery of siRNA
Jana McCaskill et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
siRNA-induced immunostimulation through TLR7 promotes antitumoral activity against HPV-driven tumors in vivo
Norliana Khairuddin et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
MicroRNAs and lung cancers: from pathogenesis to clinical implications
Ji Qi et al.
Frontiers of Medicine (2012)
Systemic delivery of E6/7 siRNA using novel lipidic particles and its application with cisplatin in cervical cancer mouse models
S. Y. Wu et al.
GENE THERAPY (2011)
Vaginal delivery of siRNA using a novel PEGylated lipoplex-entrapped alginate scaffold system
Sherry Y. Wu et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think
Camille Lobry et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Dual targeting of Bcl-2 and VEGF: A potential strategy to improve therapy for prostate cancer
Satoshi Anai et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2011)
Effective Delivery of PEGylated siRNA-Containing Lipoplexes to Extraperitoneal Tumours following Intraperitoneal Administration
Akul Singhania et al.
JOURNAL OF DRUG DELIVERY (2011)
Rational Design of Immunostimulatory siRNAs
Michael P. Gantier et al.
MOLECULAR THERAPY (2010)
A Nanoparticle System Specifically Designed to Deliver Short Interfering RNA Inhibits Tumor Growth In vivo
Nobuhiro Yagi et al.
CANCER RESEARCH (2009)
Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice
Adam D. Judge et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Development of a Novel Method for Formulating Stable siRNA-Loaded Lipid Particles for In vivo Use
Sherry Y. Wu et al.
PHARMACEUTICAL RESEARCH (2009)
Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma
Xiao-Min Yu et al.
ANNALS OF SURGERY (2008)
Tumor-targeted delivery of siRNA by self-assembled nanoparticles
Shyh-Dar Li et al.
MOLECULAR THERAPY (2008)
The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma
Xiao-Min Yu et al.
SURGERY (2008)
Papillary carcinoma of thyroid: A 30-yr clinicopathological review of the histological variants
AKY Lam et al.
ENDOCRINE PATHOLOGY (2005)
Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases
XM Yu et al.
CLINICAL CANCER RESEARCH (2005)
An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells
SM Hammond et al.
NATURE (2000)
Insular and anaplastic carcinoma of the thyroid - A 45-year comparative study at a single institution and a review of the significance of p53 and p21
KY Lam et al.
ANNALS OF SURGERY (2000)
Share Paper
